| Views | |
|---|---|
| CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study | 181 |
| March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | |
|---|---|---|---|---|---|---|---|
| CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study | 10 | 7 | 3 | 4 | 0 | 7 | 13 |
| Views | |
|---|---|
| SCOPUS19337213-2016-13-4-SID84975221908-a1.pdf | 23 |
| Views | |
|---|---|
| Russia | 83 |
| Views | |
|---|---|
| Kazan | 83 |